MarketInOut Stock Screener Log In | Sign Up

EssilorLuxottica S.A.

XETRA • Healthcare • Medical Instruments & Supplies • Quote as of 10/27/2026 17:35
EssilorLuxottica S.A. stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeXETRA
Market Capitalization83,103 mln
Float306 mln
Earnings Date02/11/2027

EPS

5.35
Stretched

P / E

33.95
Overvalued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.65
Likely reliable

Relative Strength

100 / 100
Top performer

Debt / Equity

0.39
Low leverage

Business Description

EssilorLuxottica is a Paris-based global leader in vision care, making and selling a wide range of products including prescription lenses, frames, sunglasses, and eye care equipment across dozens of well-known brands such as Ray-Ban, Oakley, Transitions, and Varilux. The company also develops advanced diagnostic and imaging tools used by eye care professionals in clinics, schools, and medical institutions worldwide. Its products reach customers through independent opticians, large retail chains, and online platforms, spanning markets across every major region of the world.

Key Fundamentals

EPS5.35
P/E33.95
ROE6.45
RPS63.46
ROIC4.51
ROA3.92
Interest Cover10.20
EBITDA, mln6,948
EV / EBITDA11.81
EV / EBIT21.48
Revenue, mln29,285
EV / Revenue2.80

Quote Details

Last 181.45
Change 6.8 (3.89%)
Open 175.35
Volume 3,798
Turnover 689,147
Average Volume 3,586.29

Financial Ratios

Pre-Tax Profit Margin12
Current Ratio0.89
Price / Book1.68
Price / Free Cash Flow16.49
Debt / Equity0.39
Price / Sales2.32
PEG Ratio1.67

Financial Strength

Altman Z-Score2.63
Piotroski F-Score 6 / 9
Beneish M-Score-2.65
Price to Intrinsic Value0.88
Price to Lynch Fair Value1.74
Shiller PE Ratio34.49

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 19.77% 100 / 100   
1 Month 24.2% 99 / 100   
2 Months 12.46% 90 / 100   
6 Months 7.18% 57 / 100   
1 Year -41.35% 4 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog